Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Breast 1

Conditions

Lung Neoplasms 6Carcinoma, Non-Small-Cell Lung 3Colonic Neoplasms 2Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Liver Neoplasms 1Disease Progression 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

pembrolizumab 6Gemcitabine 6Psychiatric Rehabilitation 5Early Intervention, Educational 5Cisplatin 5Cetuximab 5cediranib 4Oxaliplatin 4Magnetic Resonance Spectroscopy 4Leucovorin 4Fluorouracil 4Carboplatin 4Bevacizumab 4Trastuzumab 3Standard of Care 3Radiotherapy 3Pemetrexed 3Paclitaxel 3Methods 3Irinotecan 3Erlotinib Hydrochloride 3Docetaxel 3trametinib 2X-Rays 2Specimen Handling 2Mental Status and Dementia Tests 2Interleukin-12 Subunit p35 2Fluorodeoxyglucose F18 2Albumin-Bound Paclitaxel 2130-nm albumin-bound paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Rectal Neoplasms × Sevoflurane × Thoracic × Clear all
NCT04316013 2025-03-14

Volatile Anaesthesia and Perioperative Outcomes Related to Cancer: the VAPOR-C Trial

Peter MacCallum Cancer Centre, Australia

Phase 3 Terminated
254 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡